Conference Coverage
Conference Coverage
HCV increases general cancer risk
Key clinical point: Chronic hepatitis C virus (HCV) infection raises the risk of all types of cancer, not just liver cancer. Major finding: The...
Conference Coverage
ILC: Unrecognized hepatitis C linked with advanced hepatic fibrosis
Key clinical point: One-fifth of Americans with unrecognized chronic hepatitis C infection likely have advanced hepatic fibrosis. Major finding:...
Conference Coverage
ILC: New single daily pill eradicates hepatitis C
Key clinical point: Once-daily, single-pill combination treatment with grazoprevir and elbasvir for 12 weeks was safe and effective for...
Conference Coverage
VIDEO: Hepatitis C screening rises, but where are the positive cases?
Conference Coverage
VIDEO: Will new HCV drugs’ costs kill health care budgets?
Conference Coverage
VIDEO: Hepatitis C screening recommendations falling on deaf ears
Conference Coverage
VIDEO: Most baby boomers didn’t know their hep C status
Conference Coverage
Interferon-free regimen benefits HCV-infected liver transplant recipients
Key clinical point: An oral, interferon-free drug combination produced a 97% sustained virologic response rate in liver transplant recipients with...
Conference Coverage
Achieving sustained response key to successful HCV treatment
Key clinical point: Achieving a sustained virologic response to hepatitis C treatment improved long-term outcomes. Major finding: Achieving a...